These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1970550)

  • 41. ICI 204,636: a new atypical antipsychotic drug.
    Hirsch SR; Link CG; Goldstein JM; Arvanitis LA
    Br J Psychiatry Suppl; 1996 May; (29):45-56. PubMed ID: 8733823
    [No Abstract]   [Full Text] [Related]  

  • 42. [Early detection and treatment of schizophrenia].
    Hasan A; Falkai P; Wobrock T
    MMW Fortschr Med; 2010 Mar; 152(9):53-5. PubMed ID: 20384099
    [No Abstract]   [Full Text] [Related]  

  • 43. The predictive value of psychopathological subclassifications for the neuroleptic treatment outcome in schizophrenia.
    Jarema M; Kacperczyk J; Kruszynski S
    Psychopathology; 1991; 24(3):141-6. PubMed ID: 1684443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia.
    Wyatt RJ
    Schizophr Res; 1991 Oct; 5(3):201-2. PubMed ID: 1684719
    [No Abstract]   [Full Text] [Related]  

  • 45. Obsessive-compulsive symptoms in schizophrenia: their relationship with clinical features and pharmacological treatment.
    Nolfe G; Milano W; Zontini G; Petrella C; De Rosa M; Rundle-Smith S; Nolfe G
    J Psychiatr Pract; 2010 Jul; 16(4):235-42. PubMed ID: 20644358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New drug offers hope for people with schizophrenia.
    J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):46. PubMed ID: 7519676
    [No Abstract]   [Full Text] [Related]  

  • 47. Prediction and evaluation criteria in perazine therapy of acute schizophrenics. Methodological considerations, sample population, and research variables.
    Rein W; Schied HW; Breyer-Pfaff U; Straube E
    Pharmacopsychiatria; 1983 Sep; 16(5):147-51. PubMed ID: 6140693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel neuroleptics in schizophrenia: theory and clinical relevance.
    Remington GJ
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of antipsychotic drugs and symptomatology on perceptual asymmetry in schizophrenia.
    Carr V; Wale J
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1531-7. PubMed ID: 2906089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Deficit schizophrenias].
    Puech AJ
    Encephale; 1996 Jun; 22 Spec No 2():1. PubMed ID: 8767033
    [No Abstract]   [Full Text] [Related]  

  • 52. The diagnosis and treatment of children and adolescents with schizophrenia. "My mind is playing tricks on me".
    Kumra S
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):183-99, x. PubMed ID: 10674196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Psychiatric Symptom Assessment Scale (PSAS).
    Bigelow LB; Berthot BD
    Psychopharmacol Bull; 1989; 25(2):168-73. PubMed ID: 2574891
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical and therapeutic aspects of agitation].
    San L
    Encephale; 2007 Jun; 33 Pt 3():S375-9. PubMed ID: 19101354
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
    Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Weight gain and clozapine].
    Jalenques I; Tauveron I; Albuisson E; Audy V
    Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
    [No Abstract]   [Full Text] [Related]  

  • 58. Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment.
    Widerlöv E; Lindström LH; Besev G; Manberg PJ; Nemeroff CB; Breese GR; Kizer JS; Prange AJ
    Am J Psychiatry; 1982 Sep; 139(9):1122-6. PubMed ID: 6126127
    [No Abstract]   [Full Text] [Related]  

  • 59. An open multicentre study of the treatment of florid schizophrenia with remoxipride.
    McCreadie RG; Morrison D; Eccleston D; Gall RG; Loudon J; Mitchell MJ
    Acta Psychiatr Scand; 1985 Aug; 72(2):139-43. PubMed ID: 2864790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risperidone response after no clozapine response.
    Avnon M; Kunin A
    Br J Psychiatry; 1995 Nov; 167(5):699. PubMed ID: 8564340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.